Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(66), 2022
DOI: 10.1128/aac.00254-22
Links
Tools
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
Journal article published in 2022 by
E. Leegwater 
,
I. M. van der Meer,
Moes Djar,
D. J. A. R. Moes,
L. B. E. Bosma,
Bosma Lbe,
T. H. Ottens,
Ottens Th,
van der Meer Im,
C. van Nieuwkoop ,
Wilms Eb,
E. B. Wilms
,
I. M. van der Meer,
Moes Djar,
D. J. A. R. Moes,
L. B. E. Bosma,
Bosma Lbe,
T. H. Ottens,
Ottens Th,
van der Meer Im,
C. van Nieuwkoop ,
Wilms Eb,
E. B. Wilms
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
The objective of this study was to describe the population pharmacokinetics of remdesivir and GS-441524 in hospitalized coronavirus disease 2019 (COVID-19) patients. A prospective observational pharmacokinetic study was performed in non-critically ill hospitalized COVID-19 patients with hypoxemia.